169 related articles for article (PubMed ID: 19642130)
1. Antifungal prophylaxis in liver transplant recipients.
Eschenauer GA; Lam SW; Carver PL
Liver Transpl; 2009 Aug; 15(8):842-58. PubMed ID: 19642130
[TBL] [Abstract][Full Text] [Related]
2. Invasive fungal infections in liver transplantation.
Liu X; Ling Z; Li L; Ruan B
Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
[TBL] [Abstract][Full Text] [Related]
3. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
[TBL] [Abstract][Full Text] [Related]
5. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
McCoy D; Depestel DD; Carver PL
Pharmacotherapy; 2009 Nov; 29(11):1306-25. PubMed ID: 19857148
[TBL] [Abstract][Full Text] [Related]
6. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
7. Invasive aspergillosis in the recipients of liver retransplantation.
Singh N; Pruett TL; Houston S; Muñoz P; Cacciarelli TV; Wagener MM; Husain S
Liver Transpl; 2006 Aug; 12(8):1205-9. PubMed ID: 16598780
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of aspergillosis in orthotopic liver transplant recipients].
Liu ZW; Zou WL; Zhu XD; Zhang XL; Liu Y; Shen ZY
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):171-4. PubMed ID: 15760547
[TBL] [Abstract][Full Text] [Related]
9. Viral and fungal infections after liver transplantation--part II.
Kusne S; Blair JE
Liver Transpl; 2006 Jan; 12(1):2-11. PubMed ID: 16382451
[TBL] [Abstract][Full Text] [Related]
10. Antifungal prophylaxis in solid organ transplant recipients.
Brizendine KD; Vishin S; Baddley JW
Expert Rev Anti Infect Ther; 2011 May; 9(5):571-81. PubMed ID: 21609268
[TBL] [Abstract][Full Text] [Related]
11. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
12. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
Maertens J
Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
[TBL] [Abstract][Full Text] [Related]
13. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients.
San-Juan R; Aguado JM; Lumbreras C; Fortun J; Len O; Muñoz P; Montejo M; Moreno A; Cordero E; Blanes M; Ramos A; de la Torre-Cisneros J; Lopez-Medrano F; Carratala J; Moreno E;
Transplantation; 2011 Aug; 92(3):346-50. PubMed ID: 21709604
[TBL] [Abstract][Full Text] [Related]
14. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
Husain S; Tollemar J; Dominguez EA; Baumgarten K; Humar A; Paterson DL; Wagener MM; Kusne S; Singh N
Transplantation; 2003 Jun; 75(12):2023-9. PubMed ID: 12829905
[TBL] [Abstract][Full Text] [Related]
15. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
Shah T; Lai WK; Gow P; Leeming J; Mutimer D
Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic antifungal agents used after lung transplantation.
Marino E; Gallagher JC
Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for invasive aspergillosis in liver transplant recipients.
Fortún J; Martín-Dávila P; Moreno S; De Vicente E; Nuño J; Candelas A; Bárcena R; García M
Liver Transpl; 2002 Nov; 8(11):1065-70. PubMed ID: 12424722
[TBL] [Abstract][Full Text] [Related]
18. [Invasive fungal infections in patients after liver transplantation].
Fischer L; Sterneck M
Mycoses; 2005; 48 Suppl 1():27-35. PubMed ID: 15826284
[TBL] [Abstract][Full Text] [Related]
19. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.
Benedetti E; Gruessner AC; Troppmann C; Papalois BE; Sutherland DE; Dunn DL; Gruessner RW
J Am Coll Surg; 1996 Oct; 183(4):307-16. PubMed ID: 8843258
[TBL] [Abstract][Full Text] [Related]
20. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
Biancofiore G; Bindi ML; Baldassarri R; Romanelli AM; Catalano G; Filipponi F; Vagelli A; Mosca F
Transpl Int; 2002 Jul; 15(7):341-7. PubMed ID: 12122510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]